Table 1 The inferred recurrent regions of CNV in the four breast cancer datasets.
From: Inferring causal genomic alterations in breast cancer using gene expression data
Cytoband Location | Chr | Start(Mb) | End (Mb) | Size (Mb) | Gain/Loss | Important genes |
|---|---|---|---|---|---|---|
chr3q26.31-q27.1 | 3 | 173.95 | 185.91 | 11.96 | G | ECT2, PIK3CA, PSMD2, CLCN2, POLR2H |
chr4p16.3 | 4 | 0.69 | 1.95 | 1.26 | G | CTBP1, TACC3 |
chr5q35.2-q35.4 | 5 | 173.41 | 179.09 | 5.69 | G | GRK6, DDX41 |
chr8p21.2-p12 | 8 | 23.59 | 30.70 | 7.11 | L | CLU |
chr8q24.3 | 8 | 143.54 | 146.25 | 2.71 | G | NRBP2 |
chr11q13.1-q13.4 | 11 | 64.54 | 71.59 | 7.05 | G | MAP3K11, ADRBK1, RPS6KB2, LRP5, CPT1A |
chr12q24.23-q24.33 | 12 | 120.70 | 122.32 | 1.62 | G | Â |
chr16p13.4 | 16 | 2.02 | 2.66 | 0.64 | G | DCI, PDPK1 |
chr16q12.2-q22.1 | 16 | 54.25 | 69.11 | 14.87 | G | POLR2C, KIFC3, CSNK2A2, GOT2, CDH5, PSKH1, PSMB10, VPS4A, |
chr16q22.3-q24.3 | 16 | 82.56 | 88.62 | 6.06 | G | GALNS |
chr20q11.1-q11.23 | 20 | 28.24 | 36.99 | 8.75 | G | TPX2, APBA2BP, E2F1, EIF2S2, AHCY, GSS, PROCR, RBM39, SCAND1, DLGAP4, GHRH, BLCAP |
chr20q13.12-q13.13 | 20 | 44.43 | 49.01 | 4.58 | G | ARFGEF2, CSE1L |